TrialJBMR plus2026

Efficacy of romosozumab as sequential therapy for bisphosphonates in glucocorticoid-induced osteoporosis.

Mai Kawazoe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.